medicare and glp-1 coverage CMS Issues Guidance on Anti-Obesity Drugs Insurers resist medicare and medicaid
Description
Most common are gastrointestinal: nausea, vomiting, diarrhea, constipation
The Honest Risks Because There Are Real Ones I'll be direct about what we don't know, because I think patients deserve that
What separates those paths is almost entirely what you do while youre on it
Food does not significantly affect GLP-1 absorption from an injection, so eating status before injection is not critical
Unlike individual patents, which can be challenged through the Paragraph IV process, a thicket requires either challenging every patent individually (expensive and time-consuming) or negotiating around them
